Company Quick10K Filing
Cell Medx
10-Q 2020-02-29 Filed 2020-04-14
10-Q 2019-11-30 Filed 2020-01-14
10-Q 2019-08-31 Filed 2019-10-15
10-K 2019-05-31 Filed 2019-09-06
10-Q 2019-02-28 Filed 2019-04-22
10-Q 2018-11-30 Filed 2019-01-14
10-Q 2018-08-31 Filed 2018-10-15
10-K 2018-05-31 Filed 2018-09-13
10-Q 2018-02-28 Filed 2018-04-16
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-17
10-K 2017-05-31 Filed 2017-08-29
10-Q 2017-02-28 Filed 2017-04-14
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-17
10-K 2016-05-31 Filed 2016-09-13
10-Q 2016-02-29 Filed 2016-04-14
10-Q 2015-11-30 Filed 2016-01-14
10-Q 2015-08-31 Filed 2015-10-15
10-K 2015-05-31 Filed 2015-09-03
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-09
10-K 2014-05-31 Filed 2014-08-26
10-Q 2014-02-28 Filed 2014-04-18
10-Q 2013-11-30 Filed 2014-01-13
10-Q 2013-08-31 Filed 2013-10-03
10-Q 2013-02-28 Filed 2013-04-15
10-Q 2012-11-30 Filed 2013-01-16
10-Q 2012-08-31 Filed 2012-10-15
10-K 2012-05-31 Filed 2012-10-11
10-Q 2012-02-29 Filed 2012-04-09
10-Q 2011-11-30 Filed 2012-03-02
10-Q 2011-08-31 Filed 2011-10-17
10-K 2011-05-31 Filed 2011-09-21
8-K 2020-05-06 Other Events
8-K 2020-01-29 Enter Agreement, Exhibits
8-K 2019-06-24 Sale of Shares, Regulation FD, Exhibits
8-K 2019-03-21 Enter Agreement, Exhibits
8-K 2018-12-27 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-05-07 Officers, Exhibits
8-K 2018-03-23 Officers, Exhibits

Cell Medx Financials

CMXC Metrics, Comps, Filings

Quarterly | Annual

Business

We were incorporated as Plandel Resources, Inc. under the laws of the State of Nevada on March 19, 2010. On March 24, 2014, we changed our name to Sports Asylum, Inc. and on September 30, 2014, we changed our name to Cell MedX Corp. to reflect our new business direction. On April 26, 2016, we formed a subsidiary, Cell MedX (Canada) Corp., (the "Subsidiary") under the laws of the Province of British Columbia.

We are a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to: diabetes, Parkinson's disease, high blood pressure, neuropathy and kidney function. Our Subsidiary is engaged in development and manufacturing of therapeutic devices based on our proprietary eBalance Technology, which harnesses power of microcurrents and their effects on human body.

We acquired our proprietary technology for the use of microcurrents for the treatment of diabetes and related ailments, which we call eBalance Technology, on November 25, 2014, when we entered into a Technology Purchase Agreement with Jean Arnett and Bradley Hargreaves (the "Purchase Agreement").


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Corning Natural Gas (CNIG) 73,229 70% 11.4 3% 118,609 52,954 35,540 24,990 3,124 10,059 115,115
Carbon Energy (CRBO) 72,668 95% 3.1 2% 304,504 223,025 92,326 87,934 7,340 22,227 69,154
Senomyx (SNMX) 71,057 0% 0% 21,391 7,333 26,377 0 0 0 56,357
Anchor Bancorp (ANCB) 70,950 6.8 1% 478,880 410,204 0 0 2,434 10,456 70,950
RLJ Entertainment (RLJE) 70,946 46% -36.9 -5% 146,899 136,071 93,640 42,654 -7,438 -3,316 122,300
NutraFuels (NTFL) 70,032 48% -29.5 -48% 5,042 2,687 3,393 1,626 -2,423 -2,366 69,824
George Risk (RSKIA) 69,554 49% 14.1 8% 43,193 3,715 14,291 7,032 3,628 4,558 64,342
Intrusion (INTZ) 69,323 61% 15.6 62% 6,764 3,494 11,071 6,732 4,169 4,305 67,212
Cell Medx (CMXC) 5,757 -6.5 -472% 191 1,963 0 0 -899 -882 5,700
Easterly Acquisition (EACQ) 68,264 22.5 2% 146,697 10,863 0 0 3,039 3,039 68,262
Poage Bankshares (PBSK) 68,196 17.6 -1% 440,728 379,510 0 0 -2,208 2,582 45,344
Omnicomm Systems (OMCM) 67,280 81% -19.4 -44% 11,253 24,136 19,457 15,843 -4,922 -3,707 71,940
Prime Meridian Holding (PMHG) 66,178 0% -3.7 1% 484,066 429,039 142 0 2,595 4,868 -18,100
Helix TCS (HLIX) 65,696 44% -12.3 -12% 74,083 7,816 11,011 4,865 -8,865 -5,311 65,477
Yatra (TRTL) 65,640 -20.6 -3% 99,561 6,580 0 0 -3,178 -3,178 65,500
Vegalab (VEGL) 65,417 14% -32.6 -22% 10,374 4,714 11,635 1,671 -2,270 -2,012 65,545
Integrity Applications (IGAP) 64,825 0% -72.7 -44% 1,974 2,836 140 0 -874 -874 63,546
Radisys (RSYS) 64,574 27% -97.1 -33% 57,835 65,385 109,918 29,205 -19,359 -578 56,127
Peoples Financial (PFBX) 64,261 11.4 0% 617,489 523,162 0 0 553 3,135 35,782
Electrum Special Acquisition (ELECU) 64,124 -356.8 -0% 128,485 11,837 0 0 -180 -180 64,096

Balance Sheet ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-11-302019-02-282019-05-31
Cash00302424191311521100291721528381189673261082482413157
Accounts Receivable
Inventory111115143822293011606473
PP&E2826353220720720725619415411679211
Assets0030242419131152105594745481672692523793352945323761634595222191
Accounts Payable00000240159186220256302326384404397453448486515544595669706734
Long-Term Debt
Liabilities71317131313131313133935807319431,1151,3671,6811,8958801,1071,4631,5639821,0011,1191,5321,8601,963
Stockholders' Equity-7-131311116-0-2-8-11-15-20-68-288-521-684-899-1,067-1,201-1,413-1,642-502-772-1,169-1,031-605-839-1,073-1,437-1,638
Income Statement ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-11-302019-02-282019-05-31
Revenue000000000000510
Cost of Revenue-200
Gross Profit31311152000
R&D146325542516567367531044841111218346415
SG&A05310562634548705273594268445112118354348067243657
Tax
Net Income-4-6-4-20-1-6-2-6-2-4-5-48-273-419-292-1,029-480-296-334-279-1,060-305394-833-181-296-236-128-391-144
Cash Flow ($'000)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-11-302019-02-282019-05-31
Cash Operating-2-90-70-5-6-2-6-3-10-1-20-203-92-98-65-175-84-123-280-157-194-108-225-85-31-142
Cash Investing00000000000086-9-19-14-1-185-150-95000
Cash Financing29301000000001457512274186285149360142254366601625033